Expert Panel Recommends Emergency Use Of Serum's Covishield Vaccine In India : Reports
An expert panel of the Indian drugs regulator has recommended the emergency use of Serum Institute of India's Covishield vaccine, according to reports. If authorized, it would be the first COVID-19 vaccine available for emergency use in India.
The Subject Expert Committee (SEC) reportedly has recommended in favor of the EUA approval to the Drugs Controller General of India (DCGI) for Serum's Covishield vaccine.
Covishield is Serum Institute's version of the vaccine originally developed by Anglo-Swedish firm AstraZeneca and the University of Oxford.
In late December 2020, British drug major AstraZeneca's COVID-19 vaccine, co-developed by the University of Oxford, was approved for emergency supply in the UK.
The Pfizer-BioNTech COVID-19 vaccine was approved for emergency use in the U.S., which started mass vaccination on December 14. Moderna's COVID-19 vaccine also was approved for emergency use in the U.S. on December 18.
Business News
Reprinted from RTTNews，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.